Lok, J.; Iannone, V.; Gómez-Gallego, C.; Vazquez-Uribe, R.; Sommer, M.O.A.; Kolehmainen, M.; El-Nezami, H.
Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic Dysfunction-Associated Steatotic Liver Disease Mice Model. Proceedings 2023, 91, 402.
https://doi.org/10.3390/proceedings2023091402
AMA Style
Lok J, Iannone V, Gómez-Gallego C, Vazquez-Uribe R, Sommer MOA, Kolehmainen M, El-Nezami H.
Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic Dysfunction-Associated Steatotic Liver Disease Mice Model. Proceedings. 2023; 91(1):402.
https://doi.org/10.3390/proceedings2023091402
Chicago/Turabian Style
Lok, Johnson, Valeria Iannone, Carlos Gómez-Gallego, Ruben Vazquez-Uribe, Morten Otto Alexander Sommer, Marjukka Kolehmainen, and Hani El-Nezami.
2023. "Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic Dysfunction-Associated Steatotic Liver Disease Mice Model" Proceedings 91, no. 1: 402.
https://doi.org/10.3390/proceedings2023091402
APA Style
Lok, J., Iannone, V., Gómez-Gallego, C., Vazquez-Uribe, R., Sommer, M. O. A., Kolehmainen, M., & El-Nezami, H.
(2023). Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic Dysfunction-Associated Steatotic Liver Disease Mice Model. Proceedings, 91(1), 402.
https://doi.org/10.3390/proceedings2023091402
